An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03071250

Enrollment

500

Registered

2017-03-06

Start date

2018-10-01

Completion date

2019-07-01

Last updated

2019-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthritis, Hip Osteoarthritis, Knee Arthritis, Knee Osteoarthritis

Brief summary

The care for patients receiving total hip and knee arthroplasty at the University of Arkansas for Medical Sciences has followed a structured care pathway since July 2015. This system of perioperative care has focused on preoperative assessment of medical co-morbidities and risks to postoperative functional recovery, anesthetic care focused on postoperative nausea and vomiting prevention and optimizing immediate postoperative functional ability, and aggressive postoperative physical therapy. This is an observational study to look at the outcomes of this program at University of Arkansas for Medical Sciences. Areas of focus will be hospital length of stay, postoperative narcotic consumption, Visual Analog Scale scores, incidence of postoperative nausea and vomiting, and 30-day readmission rates, and health literacy rates.

Interventions

PROCEDURETotal knee or Hip Arthroplasty

Patients who received either a total knee or hip arthroplasty will be identified

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- All men and women 18 years and older who underwent total hip arthroplasty or total knee arthroplasty surgery at UAMS between 7/01/2015 and 7/01/2016.

Exclusion criteria

\- none

Design outcomes

Primary

Measure	Time frame	Description
Length of Stay	7/1/2015 - 7/1/2016	Postoperative hospital length of stay

Secondary

Measure	Time frame	Description
narcotic consumption	7/1/2015 - 7/1/2016	30-day postoperative narcotic consumption
Pain scores	7/1/2015 - 7/1/2016	postoperative VAS pain scores
30-day readmission	7/1/2015 - 7/1/2016	30-day hospital readmission following procedure
infection	7/1/2015 - 7/1/2016	Surgical site infections
PONV	7/1/2015 - 7/1/2016	postoperative nausea and vomiting

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026